Dana Johnson
spokesperson
Dana Johnson is a spokesperson for Revolution Medicines Inc., the company developing daraxonrasib, who has communicated about the drug's availability and the company's plans for expanding access to patients outside of the United States.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Dana Johnson, a spokesperson for Revolution Medicines, explained the eligibility for the FDA program.
5
Andre Bourbeau
George Zogopoulos
Jennifer Knox
Mark Johnson
Daniel Renouf
Connor Page
Jen Lovrics
Michelle Capobianco
The Globe and Mail: Drug that could extend lives of Canadians with pancreatic cancer remains out of reach for patients